Hypertension Clinical Trials in Columbus, Ohio

21 recruitingColumbus, Ohio

Showing 120 of 21 trials

Recruiting
Not Applicable

Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension

Hypertension, Pregnancy Induced
Jennifer Lewey, MD, MPH770 enrolled3 locationsNCT07209254
Recruiting
Not Applicable

BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

HypertensionHypertension, SystolicHypertension,Essential
Orchestra BioMed, Inc500 enrolled98 locationsNCT06059638
Recruiting
Phase 3

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 3

A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)

Hypertension
Eli Lilly and Company974 enrolled101 locationsNCT06948422
Recruiting
Phase 3

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2

Hypertension
Eli Lilly and Company487 enrolled99 locationsNCT06952530
Recruiting
Phase 2

Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)

Hypertension, Pulmonary
Merck Sharp & Dohme LLC130 enrolled55 locationsNCT06814145
Recruiting
Phase 3

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1

HypertensionOverweight or Obesity
Eli Lilly and Company487 enrolled99 locationsNCT06948435
Recruiting
Phase 3

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC815 enrolled63 locationsNCT07218029
Recruiting
Phase 2

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

Pulmonary Arterial Hypertension PAHPulmonary Hypertension, Interstitial Lung Disease
AllRock Bio, Inc.40 enrolled11 locationsNCT07175038
Recruiting
Phase 2

A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.

Chronic Kidney Disease and Hypertension
AstraZeneca218 enrolled70 locationsNCT07222917
Recruiting
Phase 3

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

HypertensionHigh Risk Cardiovascular DiseaseHigh Cardiovascular Risk
Alnylam Pharmaceuticals11,000 enrolled229 locationsNCT07181109
Recruiting
Phase 3

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

Chronic Kidney Disease and Hypertension
AstraZeneca5,000 enrolled753 locationsNCT06742723
Recruiting
Phase 3

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Pulmonary Hypertension
Tenax Therapeutics, Inc.230 enrolled44 locationsNCT05983250
Recruiting

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Interstitial Lung DiseasePulmonary HypertensionPulmonary Hypertension Due to Lung Diseases and Hypoxia
United Therapeutics1,000 enrolled59 locationsNCT06388421
Recruiting
Phase 2

A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

Hypertension
Novartis Pharmaceuticals380 enrolled82 locationsNCT06857955
Recruiting
Phase 4

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

PreeclampsiaHypertensive Disorders of PregnancyGestational Hypertension
Ohio State University10,742 enrolled16 locationsNCT06468202
Recruiting
Phase 1Phase 2

AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension

Open Angle GlaucomaOcular Hypertension
AbbVie96 enrolled49 locationsNCT04499248
Recruiting
Phase 4

AtorvaStatin Postpartum and Reduction of Cardiovascular risK

PreeclampsiaHypertensive Disorders of PregnancyGestational Hypertension
Ohio State University76 enrolled1 locationNCT06632379
Recruiting
Not Applicable

Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention

ObesityCardiometabolic SyndromeDiet, Healthy+9 more
Ohio State University340 enrolled1 locationNCT06055036
Recruiting
Not Applicable

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

Pulmonary HypertensionPulmonary Arterial HypertensionRight Heart Dysfunction
Aria CV, Inc30 enrolled12 locationsNCT04555161